About CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc (CTMX) is a biopharmaceutical company that focuses on developing Probody therapeutics for the treatment of cancer. The company's Probody platform utilizes masked antibodies that are designed to selectively target tumor cells, while sparing healthy cells. This targeted approach aims to enhance the efficacy and safety of cancer treatments. CTMX has a diverse pipeline of Probody therapeutics, which are at various stages of development. The company's lead product candidate is CX-072, an anti-PD-L1 Probody therapeutic that is being evaluated in multiple clinical trials for the treatment of advanced solid tumors. CTMX is also developing Probody drug conjugates (PDCs), which combine the precision targeting of Probody therapeutics with the delivery of cytotoxic agents. These PDCs have the potential to improve the treatment outcomes for patients with various types of cancer.

CTMX's stock price history has shown fluctuations over the years, influenced by various factors such as clinical trial results, regulatory approvals, and market trends. Investors should carefully analyze these factors and the company's financials before making any investment decisions. It is important to note that past performance is not indicative of future results. CTMX's market cap is a measure of its total market value, calculated by multiplying its current stock price by the total number of outstanding shares. The company's market cap can provide insights into its size and value relative to peers in the industry. CTMX's PEG ratio, which stands for the price/earnings to growth ratio, is a valuation metric that compares the company's P/E ratio to its projected earnings growth rate. A PEG ratio below 1 may suggest that the stock is undervalued, while a ratio above 1 may indicate an overvaluation. Investors should consider other factors in conjunction with the PEG ratio when evaluating an investment opportunity. CTMX's 52-week range represents the highest and lowest prices at which the stock has traded over the past year. This range provides insights into the stock's volatility and potential for price appreciation or decline. The day range of CTMX represents the highest and lowest prices at which the stock has traded during a particular trading session. This range can provide insights into the stock's intraday volatility and the level of investor interest. CTMX's trading volume refers to the total number of shares traded during a given period, typically measured in an average daily volume. This metric can provide insights into the liquidity and investor interest in the stock.